Jawed Zia has joined as the Chief Executive Officer of Cadila Pharmaceuticals, one of the largest privately-held pharma companies in the country.

Zia, will lead the strategy and business operations of Cadila’s branded prescriptions pharmaceuticals business. A seasoned industry professional with more than three-and-a-half decades of experience, he last served as vice chairman of healthcare start-up Rivaara Holdings.

A strategic thinker with versatile experience, Zia has deep knowledge and extensive experience in building and managing businesses in the healthcare Industry. His innate ability to drive the growth of people and businesses, build brands, transform operations and scale capabilities has been the hallmark of his success.

A graduate of Clinical Pharmacology from the All India Institute of Medical Sciences, New Delhi, Zia studied business administration at Trinity College, Dublin. He joined Novartis in 1987 and had a successful career passing over 30 years across market research, brand management, marketing, and other functions in Ireland, Singapore, Saudi Arabia, Canada, Switzerland, Turkey, and India. His experience includes roles in Rx Pharmaceuticals, Consumer Health and Medical Devices and Instrumentations. He also led Abbott India operations.

“Cadila Pharmaceuticals is one of the oldest and most respected drug manufacturers in the country. It is committed to providing high-quality yet affordable drugs to patients around the world. I look forward to working with the amazing team at Cadila Pharmaceuticals and driving its growth while upholding its fundamental principles,” commented Zia on his appointment.